DASATINIB FORMULIERUNG

European patent · EP3419605 · In force

Register entry

Publication number
EP3419605
Application number
EP16706358
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 25, 2016
Published
Jan 2, 2019
Granted
Apr 8, 2026
Protection ends at the latest
Feb 24, 2036
Next annual fee due
Feb 28, 2027
IPC classes
A61K 9/16 (2006.01)
A61K 9/20 (2006.01)
A61K 31/506 (2006.01)
A61P 35/02 (2006.01)
PCT application
PCT/EP2016/054037 25.02.2016
PCT publication
WO2017/144109 31.08.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 8, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 08.04.2026

Parties

Inventor

PATTIHIS, Charalambos

Limassol 3508, CY

NORDMANN, Antje

Limassol 3508, CY

PANAGOPOULOS, Panagiotis

14452 Metamorfossi Attikis, GR

PANITSAS, Konstantinos-Emmanouil

14452 Metamorfossi Attikis, GR

ALEXAKI, Pandora

14452 Metamorfossi Attikis, GR

KATAKALOU, Christina

14452 Metamorfossi Attikis, GR

VIDALIS, Matthew

14452 Metamorfossi Attikis, GR

KATHIOTOU, Georgia

14452 Metamorfossi Attikis, GR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.